Multicell Technologies, Revenue Growth Rates (MCET), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Multicell Technologies, Inc.  (MCET)
 

MCET's Revenue Growth by Quarter and Year

Multicell Technologies,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MCET Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
4th Quarter November -
3rd Quarter August -
2nd Quarter May 0.59
1st Quarter February 0.01
FY 0.60





MCET Revenue second quarter 2015 Y/Y Growth Comment
Multicell Technologies, Inc. achieved in the second quarter 2015, above Company average Revenue surge of 5758.05% year on year, to $ 0.59 millions.

According to the results reported in the second quarter 2015, Multicell Technologies, Inc. achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While Multicell Technologies, Inc.' s Revenue doubling of 5758.05% ranks overall at the positon no. 20 in the second quarter 2015.


MCET Revenue ( Y/Y Growth %) 2015
 2014 2013 2012
4th Quarter November - 0 % 0 % 0 %
3rd Quarter August - 0 % 0 % 0 %
2nd Quarter May 5758.05 % 0 % 0 % 0 %
1st Quarter February 0 % 0 % 0 % 0 %
FY   - 0 % 0 % -

Financial Statements
Multicell Technologies,'s second quarter 2015 Revenue $ 0.59 millions MCET's Income Statement
Multicell Technologies,'s second quarter 2014 Revenue $ 0.01 millions Quarterly MCET's Income Statement


MCET Revenue (Quarter on Quarter Growth %)

 2015
 2014 2013 2012
4th Quarter November - 0 % 0 % 0 %
3rd Quarter August - 0 % 0 % 0 %
2nd Quarter May 5758.05 % 0 % 0 % 0 %
1st Quarter February 0 % 0 % 0 % 0 %
FY (Year on Year)   - 0 % 0 % -


Back to MCET Growth rate Comparisons >> Back to MCET Growth rate Comparisons >>


Revenue second quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #0
Healthcare Sector #3
Overall #20

Revenue Y/Y Growth Statistics
High Average Low
4651.05 % 310.07 % -0.71 %
(May 31 2015)   (Feb 28 2015)
Revenue second quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #0
Healthcare Sector #3
Overall #20
Revenue Y/Y Growth Statistics
High Average Low
4651.05 % 310.07 % -0.71 %
(May 31 2015)   (Feb 28 2015)

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

Multicell Technologies,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
4651.44 % 357.8 % -0.01 %
(May 31 2015)  


MCET's II. Quarter Q/Q Revenue Comment
Multicell Technologies, Inc. achieved in the II. Quarter 2015 above company average sequential Revenue doubling of 5758.05%, to $ 0.59 millions, from $0.01 millions in the first quarter.
MCET is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Biotechnology & Pharmaceuticals industry only one company achieved higher sequential Revenue growth. While Multicell Technologies,'s Revenue growth quarter on quarter, overall rank is 12.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #2
Overall #12
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #2
Overall #12
Revenue Q/Q Growth Statistics
High Average Low
4651.44 % 357.8 % -0.01 %
(May 31 2015)  


MCET's II. Quarter Q/Q Revenue Comment
Multicell Technologies, Inc. achieved in the II. Quarter 2015 above company average sequential Revenue doubling of 5758.05%, to $ 0.59 millions, from $0.01 millions in the first quarter.
MCET is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Biotechnology & Pharmaceuticals industry only one company achieved higher sequential Revenue growth. While Multicell Technologies,'s Revenue growth quarter on quarter, overall rank is 12.


Multicell Technologies,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2015)		 12 Months Ending
(Feb 28 2015)		 12 Months Ending
(Nov 30 2014)		 12 Months Ending
(Aug 31 2014)		 12 Months Ending
(May 31 2014)
Cumulative Revenue 12 Months Ending $ 0.62 $ 0.05 $ 0.05 $ 0.05 $ 0.05
Y / Y Revenue Growth (TTM) 1162.81 % 0 % 0 % 0 % 0 %
Year on Year Revenue Growth Overall Ranking # 16 # 24 # 0 # 0 # 16
Seqeuential Revenue Change (TTM) 1162.81 % 0 % 0 % 0 % 0 %
Seq. Revenue Growth (TTM) Overall Ranking # 16 # 3 # 0 # 0 # 18


Cumulative Revenue growth Comment
With 1162.81% annual Revenue growth, Multicell Technologies, Inc. would report a record annual Revenue surge if the fiscal year would end on May 31 2015.

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 16, from total ranking in previous quarter at 24.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 2
Healthcare Sector # 4
Overall # 16

Revenue TTM Y/Y Growth Statistics
High Average Low
1162.81 %
 166.12 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 4
S&P 500 # 16
Cumulative Revenue growth Comment
With 1162.81% annual Revenue growth, Multicell Technologies, Inc. would report a record annual Revenue surge if the fiscal year would end on May 31 2015.

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 16, from total ranking in previous quarter at 24.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 2
Healthcare Sector # 4
Overall # 16

Revenue TTM Y/Y Growth Statistics
High Average Low
1162.81 %
166.12 %
0 %
 






Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MCET's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending May 31 2015 within Healthcare SectorY/Y Change %Revenue for the quarter ending May 31 2015
Multicell Technologies, Inc.4,651.05%$ 4,651.054 millions


About Multicell Technologies, Revenue Growth Rates (MCET), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.